BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6974591)

  • 1. Presence of the Philadelphia chromosome (Ph1) in pokeweed mitogen stimulated lymphocytes during chronic phase of chronic myelocytic leukemia (CML).
    Juneja HS; Weiner R
    Cancer Genet Cytogenet; 1981 Aug; 4(1):39-44. PubMed ID: 6974591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ph1-negative T lymphocytic colonies in agar cultures of peripheral blood in chronic myeloid leukemia.
    Bagnara GP; Biagini G; Marani M; Bonsi L; Severi B; Valvassori L; Comis M; Nobile F; Iacopino P; Ronco F; Neri A
    Acta Haematol; 1981; 66(3):174-80. PubMed ID: 6795875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myelogenous leukemia with a complex Ph1 translocation in an XYY male.
    Ohyashiki K; Oshimura M; Toyoda T; Sakai N; Ito H; Yamamoto K; Tonomura A
    Cancer Genet Cytogenet; 1984 Feb; 11(2):215-9. PubMed ID: 6607101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9;22;15 complex translocation in Ph1 chromosome positive CML revealed by Giemsa-11 procedure in apparent lymphoid cells of blastic crisis.
    Hays T; Morse HG; Robinson A
    Cancer Genet Cytogenet; 1981 Dec; 4(4):283-92. PubMed ID: 6949632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1-negative chronic myelocytic leukemia (CML).
    Kohno S; Abe S; Sandberg AA
    Am J Hematol; 1979; 7(3):281-91. PubMed ID: 296877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New complex Ph' translocation t (10; 14; 22) in bone marrow cells and in PHA-stimulated peripheral blood cultures in chronic myelocytic leukaemia.
    Shabtai F; Gafter U; Weiss S; Djaldetti M; Halbrecht I
    J Cancer Res Clin Oncol; 1980; 96(3):287-94. PubMed ID: 6933152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant Ph1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises.
    Oshimura M; Ohyashiki K; Terada H; Takaku F; Tonomura A
    Cancer Genet Cytogenet; 1982 Mar; 5(3):187-201. PubMed ID: 6950809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal evolution of karyotype in blastic phase of CML.
    Izakovic V; HorĂ¡k I; Krizan P
    Neoplasma; 1982; 29(5):613-23. PubMed ID: 6960260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Triple Philadelphia chromosome during blastic crisis of a chronic myelocytic leukemia].
    Cabrol C; Peytremann R; Maurice PA; Klein D
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1381. PubMed ID: 1070157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of expression of the fragile site at Xq27 in T and B lymphocytes.
    Marchese CA; Lin MS; Wilson MG
    Hum Genet; 1984; 67(2):213. PubMed ID: 6611290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Masked" philadelphia chromosome (Ph1) due to an unusual translocation.
    Marinello MJ; Morita M; Sandberg AA
    Cancer Genet Cytogenet; 1981 Apr; 3(3):227-32. PubMed ID: 6945148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell.
    Fialkow PJ; Jacobson RJ; Singer JW; Sacher RA; McGuffin RW; Neefe JR
    Blood; 1980 Jul; 56(1):70-3. PubMed ID: 6930309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia presenting in the blastic phase and its association with a 45 XO Ph1 karyotype.
    Nigam R; Dosik H
    Blood; 1976 Feb; 47(2):223-7. PubMed ID: 1060474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia.
    Nitta M; Kato Y; Strife A; Wachter M; Fried J; Perez A; Jhanwar S; Duigou-Osterndorf R; Chaganti RS; Clarkson B
    Blood; 1985 Nov; 66(5):1053-61. PubMed ID: 2996659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.
    Bartram CR; de Klein A; Hagemeijer A; Grosveld G; Heisterkamp N; Groffen J
    Blood; 1984 Jan; 63(1):223-5. PubMed ID: 6336312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chromosomes and causation of human cancer and leukemia. XVIII. The missing Y in acute myeloblastic leukemia (AML) and Ph1-positive chronic myelocytic leukemia (CML).
    Sakurai M; Sandberg AA
    Cancer; 1976 Aug; 38(2):762-9. PubMed ID: 1067892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and cytogenetic significance of C-banding on chromosome #9 in patients with Ph1-positive chronic myeloid leukemia.
    Sadamori N; Sandberg AA
    Cancer Genet Cytogenet; 1983 Mar; 8(3):235-41. PubMed ID: 6572094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of chronic lymphatic leukaemia cells by pokeweed mitogen after treatment with neuraminidase-galactose oxidase.
    Zafar MN; Pittman S; Cherchi M; Catovsky D
    Clin Exp Immunol; 1981 Apr; 44(1):124-8. PubMed ID: 6973427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell involvement in benign phase chronic myelogenous leukemia.
    Nogueira-Costa R; Spitzer G; Khorana S; Pham Q; Kantarjian HM; Manning JT; Ordonez NG; Dicke KA
    Leuk Res; 1986; 10(12):1433-9. PubMed ID: 3099099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Philadelphia-chromosome-negative chronic myelogenous leukemia with lymphoid stem cell blastic transformation.
    Kessler JF; Grogan TM; Greenberg BR
    Am J Hematol; 1985 Feb; 18(2):201-6. PubMed ID: 3855600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.